Landscapes / Companies

Incyte Biosciences Japan GK not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
 
Next date
None yet
 
Drugs
2
in active trials · 6 in all
Trials
2 active
6 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Incyte · Syndax Pharmaceuticals
Approved —
Monoclonal antibody
Incyte Corporation · MorphoSys
Approved —

About

No active trial
INCB001158, INCB086550, Povorcitinib, Retifanlimab
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Incyte Biosciences Japan GK

Following is part of Solo: you see every change to Incyte Biosciences Japan GK the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in